Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-17-011057
Filing Date
2017-11-13
Accepted
2017-11-13 06:30:25
Documents
6
Period of Report
2017-11-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp82758_6k.htm 6-K 14401
2 EXHIBIT 99.1 dp82758_ex9901.htm EX-99.1 157642
3 EXHIBIT 99.2 dp82758_ex9902.htm EX-99.2 136417
4 EXHIBIT 99.3 dp82758_ex9903.htm EX-99.3 61617
5 GRAPHIC image_001.jpg GRAPHIC 10680
6 GRAPHIC image_002.jpg GRAPHIC 8975
  Complete submission text file 0000950103-17-011057.txt   398423
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 171192873
SIC: 2834 Pharmaceutical Preparations